Cytomx Therapeutics, Inc. · NASDAQ:CTMX

BVF PARTNERS L P/IL reported a 6.80% stake in Cytomx Therapeutics, Inc. (Schedule 13G/A)

Event Jun 30, 2025 · Filed Jul 9, 2025

BVF PARTNERS L P/IL reported a 6.80% stake in Cytomx Therapeutics, Inc., 11,538,462 shares, as a passive investor on Jun 30, 2025. Filed Jul 9, 2025 (Schedule 13G/A).

Stake
6.80%
Shares
11,538,462
Intent
Passive
What changed
Stake changed
Filed together
10 holders

The filing in full

HolderStakeShares
BIOTECHNOLOGY VALUE FUND L P3.80%6,148,026
BVF I GP LLC3.80%6,148,026
BIOTECHNOLOGY VALUE FUND II LP2.90%4,702,892
BVF II GP LLC2.90%4,702,892
Biotechnology Value Trading Fund OS LP0.30%541,232
BVF Partners OS Ltd.0.30%541,232
BVF GP HOLDINGS LLC6.40%10,850,918
BVF PARTNERS L P/IL6.80%11,538,462
BVF INC/IL6.80%11,538,462
LAMPERT MARK N6.80%11,538,462

Source

View original at SEC

Related